Cargando…
Targeting Hepatic Glucokinase in Type 2 Diabetes: Weighing the Benefits and Risks
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606869/ https://www.ncbi.nlm.nih.gov/pubmed/19114725 http://dx.doi.org/10.2337/db08-1470 |
| _version_ | 1782163000627560448 |
|---|---|
| author | Agius, Loranne |
| author_facet | Agius, Loranne |
| author_sort | Agius, Loranne |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2606869 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-26068692010-01-01 Targeting Hepatic Glucokinase in Type 2 Diabetes: Weighing the Benefits and Risks Agius, Loranne Diabetes Commentaries American Diabetes Association 2009-01 /pmc/articles/PMC2606869/ /pubmed/19114725 http://dx.doi.org/10.2337/db08-1470 Text en Copyright © 2009, American Diabetes Association Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
| spellingShingle | Commentaries Agius, Loranne Targeting Hepatic Glucokinase in Type 2 Diabetes: Weighing the Benefits and Risks |
| title | Targeting Hepatic Glucokinase in Type 2 Diabetes: Weighing the Benefits and Risks |
| title_full | Targeting Hepatic Glucokinase in Type 2 Diabetes: Weighing the Benefits and Risks |
| title_fullStr | Targeting Hepatic Glucokinase in Type 2 Diabetes: Weighing the Benefits and Risks |
| title_full_unstemmed | Targeting Hepatic Glucokinase in Type 2 Diabetes: Weighing the Benefits and Risks |
| title_short | Targeting Hepatic Glucokinase in Type 2 Diabetes: Weighing the Benefits and Risks |
| title_sort | targeting hepatic glucokinase in type 2 diabetes: weighing the benefits and risks |
| topic | Commentaries |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606869/ https://www.ncbi.nlm.nih.gov/pubmed/19114725 http://dx.doi.org/10.2337/db08-1470 |
| work_keys_str_mv | AT agiusloranne targetinghepaticglucokinaseintype2diabetesweighingthebenefitsandrisks |